Arkolith/Insider Trading/STSA/Form 4

Leonard Braden Michael

10% OwnerSatsuma Pharmaceuticals, Inc. (STSA) · full profile →Form 4 · filed Nov 16, 2022
Net Buying
Open-Market Buys
$4.4M
Open-Market Sells
$0
Net Open-Market Flow
$4.4M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2022Buy(P)301K$0.63$189K6.4M
Nov 15, 2022Buy(P)531K$0.63$335K6.1M
Nov 14, 2022Buy(P)5.6M$0.69$3.9M5.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-020458) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML